| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Flucloxacillin Sodium | Flucloxacillin EP Impurity A | VE008932 | View CAS 68728-50-7 |
| Flucloxacillin Sodium | Flucloxacillin EP Impurity B | VE008934 | View CAS 1276016-89-7 |
| Flucloxacillin Sodium | Flucloxacillin EP Impurity E | VE008936 | View |
| Flucloxacillin Sodium | Flucloxacillin Sodium Hydrate Inhouse Impurity F | VE008925 | View CAS 866150-92-7 |
| Catalogue No. | VE008934 |
| CAS No. | 1276016-89-7 |
| Molecular Formula | C18H19ClFN3O4S |
| Molecular Weight | 427.88 g/mol |
| Parent drug | Flucloxacillin Sodium |
| IUPAC Name | (2RS, 4S)-2-[[[[3-(2-chloro-6-fluorophenyl)-5-methyl-1, 2-oxazol-4-yl]carbonyl]amino]methyl]-5, 5-dimethyl-1, 3-thiazolidine-4-carboxylic acid |
| Synonyms | Penilloic acids of flucloxacillin |
| References | Francis, Nick A., et al. “Understanding Flucloxacillin Prescribing Trends and Treatment Non-Response in UK Primary Care: A Clinical Practice Research Datalink (CPRD) Study.” Journal of Antimicrobial Chemotherapy, vol. 71, no. 7, Apr. 2016, pp. 2037–46, https://doi.org/10.1093/jac/dkw084. |
| Status | In-stock |
| ListName | Flucloxacillin EP Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
